Profile
ABVC VRTX ALNY REGN ARGX SGEN
Company Name ABVC BioPharma, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $41.59M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.02K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Uttam Yashwant Patil Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
ABVC VRTX ALNY REGN ARGX SGEN
Quant Rating Score 1 4 1 4 4 3
Quant Rating Strong Sell Buy Strong Sell Buy Buy Neutral
Trading
ABVC VRTX ALNY REGN ARGX SGEN
Last Close $2.84 $391.36 $461.24 $575.06 $752.32 $228.74
High 52 $4.76 $516.74 $482.13 $1150.19 $768 $228.74
Low 52 $0.41 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -40.34 % -24.26 % -4.33 % -50 % -2.04 % 0 %
Price vs. 52 Week Low 592.68 % 6.77 % 105.38 % 19.08 % 44.74 % 0 %
Total Return
ABVC VRTX ALNY REGN ARGX SGEN
1 Month Return -13.94 % -0.36 % 2.75 % -0.92 % 15.06 % 0 %
3 Month Return 42 % -11.46 % 49.37 % 12.99 % 39.14 % 0 %
6 Month Return 336.52 % -23.82 % 82.16 % -15.15 % 22.49 % 0 %
9 Month Return 489.82 % -16.6 % 87.05 % -22.29 % 17.86 % 0 %
YTD Return 381.36 % -2.82 % 96.01 % -19.27 % 22.33 % 0 %
1 Year Return 325.4 % -18.68 % 68.05 % -49.85 % 44.06 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVC VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -7.5415073052426E+15 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
ABVC VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 50.14 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -18.82 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -55.56 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -33.7 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 93.8 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 99.58 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -836.32 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -110.75 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM 0.28 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM - 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM 17.2 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 4.51 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 2.41 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.1 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -0.1 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 2.61 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -448.8 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -110.75 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -23.68 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -28.42 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -28.42 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
ABVC VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 99.85% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -0.42 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
ABVC VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.01B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.01B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
ABVC VRTX ALNY REGN ARGX SGEN
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.2
AARD Aardvark Therapeutics, Inc. Common Stock 10.99
ABCL AbCellera Biologics Inc. 4.565
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.635
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.255
ABPWW 0.046281
ABSI Absci Corporation 2.555
ABUS Arbutus Biopharma Corporation 4.425
ABVX Abivax SA American Depositary Shares 81.05
ACAD ACADIA Pharmaceuticals Inc. 24.2
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7602
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.965
ACIU AC Immune SA 2.46
ACLX Arcellx, Inc. 76.42
ETFs With Exposure to ABVC
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 325.11
VXF Vanguard Extended Market Index Fund 0.00051 209.23
IWC iShares Micro-Cap ETF 0 146.14
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00044 158.72
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00044 158.73
VEMPX Vanguard Extended Market Index InstlPlus 0.00044 391.7
Unlock